NOV 10, 2020 8:05 AM PST

No More False-Negatives: An Ultrasensitive COVID Test

WRITTEN BY: Tara Fernandez

A team of researchers has improved upon the current diagnostic methodology for COVID-19, making it significantly more accurate and reliable. The new cost-effective test that builds upon the commonly-used Reverse Transcription Polymerase Chain Reaction or RT-PCR protocol incorporates state-of-the-art microfluidic technology. Scientists have shown that this technique is capable of detecting even trace amounts of viral genetic material, thus significantly diminishing the risk of false-negative results.

The accuracy of COVID-19 diagnostics, or lack thereof, has been an ongoing issue since the emergence of the disease almost a year ago. These tests can be wrong in one of two ways: either a false positive or a false negative. False positives (where a person is wrongly classed as being infected) lead to unnecessary quarantining and stress for the patient. False negatives, however, are far more concerning. In these cases, asymptomatic individuals harboring the virus can continue to unwittingly infect others in the course of their daily lives, lulled into a false sense of security as a result of the negative result.

The new and improved ultrasensitive diagnostic system, created by scientists at NYU Abu Dhabi's Biology Program and Center for Genomics and Systems Biology (CGSB), uses three sequential steps to boost the test’s accuracy: RT and cDNA preamplification followed by qPCR. This enables extremely minute amounts of viral RNA present in nasal swabs and saliva samples from getting detected, slashing false-negative rates. The work detailing the development of this microfluidic-based test was presented in the journal Processes.

"By adding a pre-amplification step and using microfluidic technology, we have demonstrated that this sensitive detection method can detect low viral loads, which is critical to enabling the most effective public health responses to the COVID-19 pandemic," said Youssef Idaghdour, a researcher who led the study. 

"Our three-step approach can significantly reduce the false-negative rate of standard RT-PCR-based diagnostic tests for SARS-CoV2 and other viral infections. This would allow public health officials to more readily identify and trace asymptomatic individuals, enhance the accuracy of air and environmental sampling for SARS-CoV-2, expand accurate detection to saliva testing and help curtail the spread of the virus."

 

 

Sources: Eurekalert, Processes.

 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
MAY 26, 2021
Chemistry & Physics
Turning bullfrog skin into human bones - as easy as....?
MAY 26, 2021
Turning bullfrog skin into human bones - as easy as....?
In an effort to support the growth of the circular economy, researchers from Nanyang Technological University, Singapore ...
MAY 31, 2021
Clinical & Molecular DX
Researchers Create the First Saliva Wiki
MAY 31, 2021
Researchers Create the First Saliva Wiki
A new digital platform, developed by researchers at the University at Buffalo, is answering the question: what’s o ...
JUN 04, 2021
Clinical & Molecular DX
Tiny Bone Marrow Models Help Tailor Treatments for Platelet Disorder Patients
JUN 04, 2021
Tiny Bone Marrow Models Help Tailor Treatments for Platelet Disorder Patients
  Scientists have developed miniaturized 3-dimensional bone marrow models that could help physicians to predict whi ...
JUL 15, 2021
Technology
Raman Spectroscopy Helps Track IBD Patient Response to Treatment
JUL 15, 2021
Raman Spectroscopy Helps Track IBD Patient Response to Treatment
While there have been multiple methods of evaluating whether a patient with inflammatory bowel disease (IBD) is respondi ...
AUG 17, 2021
Clinical & Molecular DX
Sleep Apnea Doubles the Risk of Sudden Death
AUG 17, 2021
Sleep Apnea Doubles the Risk of Sudden Death
Obstructive sleep apnea, or OSA, is the most commonly reported sleep disorder, with loud snoring being one of the tell-t ...
AUG 29, 2021
Cancer
Blood Test over 90% Accurate in Detecting Lung Cancer
AUG 29, 2021
Blood Test over 90% Accurate in Detecting Lung Cancer
An AI-powered blood test was able to correctly detect the presence of lung cancer over 90% of the time in patient sample ...
Loading Comments...